Qube Research & Technologies (QRT)
IMUX icon

Qube Research & Technologies (QRT)’s Immunic IMUX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$124K Buy
+11,146
New +$99.8K ﹤0.01% 3039
2025
Q4 		– Sell
-3,267
Closed -$28.8K – 3860
2025
Q3 		$28.8K Buy
+3,267
New +$28.8K ﹤0.01% 3256
2025
Q2 		– Sell
-3,499
Closed -$38.1K – 3737
2025
Q1 		$38.1K Sell
3,499
-13,077
-79% -$141K ﹤0.01% 3155
2024
Q4 		$166K Sell
16,576
-920
-5% -$11.6K ﹤0.01% 2880
2024
Q3 		$289K Buy
17,496
+17,491
+349,820% +$249K ﹤0.01% 2441
2024
Q2 		$56 Buy
+5
New +$62 ﹤0.01% 3495
2024
Q1 		– Sell
-6
Closed -$87 – 4665
2023
Q4 		$87 Hold
6
– – ﹤0.01% 4034
2023
Q3 		$85 Buy
+6
New +$115 ﹤0.01% 3776
2022
Q4 		– Sell
-1,434
Closed -$45K – 2722
2022
Q3 		$45K Sell
1,434
-137
-9% -$5.73K ﹤0.01% 2158
2022
Q2 		$55K Buy
+1,571
New +$101K ﹤0.01% 2101

Other funds holding IMUX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Qube Research & Technologies (QRT)'s IMUX Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Immunic (IMUX) in Q1 2026: 11,146 shares worth $124K. The stake represents ﹤0.01% of the portfolio and ranks #3039 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in IMUX as recently as Q3 2025.

Qube Research & Technologies (QRT) first reported a position in IMUX in Q2 2022 and has held it in 10 quarters since. The position peaked at $289K in Q3 2024. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

  • Qube Research & Technologies (QRT) held 11,146 shares of Immunic worth $124K as of Q1 2026.
  • Immunic was a new Qube Research & Technologies (QRT) position in Q1 2026.
  • Immunic made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #3039 holding.
  • Qube Research & Technologies (QRT) first reported a position in Immunic in Q2 2022 and has held it in 10 quarters since.
  • Qube Research & Technologies (QRT)'s Immunic position peaked at $289K in Q3 2024.
  • 75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.